DarioHealth Corp. Warrant
DRIOW
DRIOW was delisted on the 4th of March, 2021.
2 hedge funds and large institutions have $2K invested in DarioHealth Corp. Warrant in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more capital invested
Capital invested by funds: $1K → $2K (+$1K)
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$55 |
DRIOW Hedge Fund Activity: Q2 2020 in Review
2 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q2 2020, worth a combined $2K — up 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of DRIOW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $1K sold.
- 2 institutional investors held DarioHealth Corp. Warrant (DRIOW) as of Q2 2020, down from 3 in Q1 2020.
- Funds reported $2K of DarioHealth Corp. Warrant stock for Q2 2020, up 100% quarter-over-quarter.
- 1 fund opened new DarioHealth Corp. Warrant positions in Q2 2020 and 2 closed out, a net change of -1 holder.
- The largest DarioHealth Corp. Warrant seller in Q2 2020 was Susquehanna International Group, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2020.